Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 32, Issue 4, 2009, Pages 411-416

  Macdonald, O Kenneth ^a   Chen, Jergin ^b   Dodson, Mark ^b   Lee, Christopher M ^c   Gaffney, David K ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Cancer Care Northwest   (United States)

Author keywords

Carcinoma; Lymph node; Surgery; Uterine cervix

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; DATA BASE; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PELVIS; PREDICTION; PROGNOSIS; RADICAL HYSTERECTOMY; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 69349094921     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31819142dc     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; 2007.
3. Landoni F, Maneo A, Colombo A, et al. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535-540. (Pubitemid 27348428)
4. Hsu CT, Cheng YS, Su SC. Prognosis of uterine cervical cancer with extensive lymph node metastases. Special emphasis on the value of pelvic lymphadenectomy in the surgical treatment of uterine cervical cancer. Am J Obstet Gynecol. 1972;114:954-962.
5. Piver MS, Barlow JJ, Krishnamsetty R. Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. Am J Obstet Gynecol. 1981;139:575-578. (Pubitemid 11126152)
6. Alvarez RD, Soong SJ, Kinney WK, et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol. 1989;35:130-135.
7. Lai CH, Hong JH, Hsueh S, et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer. 1999;85:1537-1546. (Pubitemid 29152826)
8. Delgado G, Bundy B, Zaino R, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:352-357. (Pubitemid 20362555)
9. Institute NC. Surveillance epidemiology and end results (SEER). 2007.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 1958;53:457-481.
11. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
12. Terada KY, Morley GW, Roberts JA. Stage IB carcinoma of the cervix with lymph node metastases. Gynecol Oncol. 1988;31:389-395. (Pubitemid 18273547)
13. Grisaru D, Covens A, Chapman B, et al. Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer. 2001;92:2999-3004. (Pubitemid 33136194)
14. Yasuda S, Kojima A, Maeno Y, et al. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis. Kobe J Med Sci. 2006;52:9-15.
15. Kamura T, Tsukamoto N, Tsuruchi N, et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 1992;69:181-186.
16. Sakuragi N, Satoh C, Tanaka T, et al. [The incidence and clinical significance of paraaortic lymph node metastases in patients with uterine cervical cancer.] Nippon Sanka Fujinka Gakkai Zasshi. 1990;42:60-66.
17. Girardi F, Haas J. The importance of the histologic processing of pelvic lymph nodes in the treatment of cervical cancer. Int J Gynecol Cancer. 1993;3:12-17. (Pubitemid 23207591)
18. Goff BA, Muntz HG, Paley PJ, et al. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol. 1999;74:436-442. (Pubitemid 29439886)
19. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer. 1990;65:1923-1927. (Pubitemid 20147629)
20. Denschlag D, Gabriel B, Mueller-Lantzsch C, et al. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer. Gynecol Oncol. 2005;96:658-664. (Pubitemid 40255484)
21. Feng SY, Zhang YN, Liu JG. [Risk factors and prognosis of node-positive cervical carcinoma.] Ai Zheng. 2005;24:1261-1266.
22. Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85:1547-1554. (Pubitemid 29152827)
23. Kamura T, Shigematsu T, Kaku T, et al. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Acta Obstet Gynecol Scand. 1999;78:452-457. (Pubitemid 29199685)
24. Berman ML, Keys H, Creasman W, et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984;19:8-16. (Pubitemid 14027471)
25. Keys HM, Bundy BN, Stehman FB, et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol. 2003;89:343-353.
26. Cosin JA, Fowler JM, Chen MD, et al. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer. 1998;82:2241-2248.
27. Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer. 1995;5:250-256.
28. Kinney WK, Hodge DO, Egorshin EV, et al. Surgical treatment of patients with stages IB and IIA carcinoma of the cervix and palpably positive pelvic lymph nodes. Gynecol Oncol. 1995;57:145-149.
29. van de Lande J, Torrenga B, Raijmakers PG, et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol. 2007;106:604-613. (Pubitemid 47302470)
30. Ishikawa H, Nakanishi T, Inoue T, et al. Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol. 1999;73:42-46. (Pubitemid 29177597)
31. Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiol Oncol. 1984;23:455-459. (Pubitemid 15073560)
32. Celen O, Yildirim E, Berberoglu U. Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol. 2007;96:95-101. (Pubitemid 47264811)
33. Chan JK, Kapp DS, Cheung MK, et al. The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients. Br J Cancer. 2007;97:605-611.
34. Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141:610-618. (Pubitemid 46616937)
35. Wijnhoven BP, Tran KT, Esterman A, et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007;245:717-725. (Pubitemid 46684101)
36. Yildirim E, Berberoglu U. Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients. World J Surg. 2007;31:276-289. (Pubitemid 46183511)